These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Biologic aspects of thrombopoietins and the development of therapeutic agents. Solberg LA Curr Hematol Rep; 2005 Nov; 4(6):423-8. PubMed ID: 16232377 [TBL] [Abstract][Full Text] [Related]
6. Thrombopoietic growth factors in the treatment of immune thrombocytopenic purpura. Wang T; Wang Z; Yang R Crit Rev Oncol Hematol; 2011 Mar; 77(3):172-83. PubMed ID: 20378370 [TBL] [Abstract][Full Text] [Related]
10. Biologic aspects of thrombopoietin and the development of novel thrombopoietic agents for clinical use. Evangelista ML; Amadori S; Stasi R Curr Drug Discov Technol; 2007 Oct; 4(3):162-73. PubMed ID: 17985999 [TBL] [Abstract][Full Text] [Related]
11. The biology of thrombopoietin and thrombopoietin receptor agonists. Kuter DJ Int J Hematol; 2013 Jul; 98(1):10-23. PubMed ID: 23821332 [TBL] [Abstract][Full Text] [Related]
12. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Kuter DJ; Begley CG Blood; 2002 Nov; 100(10):3457-69. PubMed ID: 12411315 [TBL] [Abstract][Full Text] [Related]
13. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL. Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539 [TBL] [Abstract][Full Text] [Related]
14. Thrombopoietin (Mpl-ligand) and the regulation of platelet production. Cohen-Solal K; Debili N; Vainchenker W; Wendling F Thromb Haemost; 1997 Jul; 78(1):37-41. PubMed ID: 9198124 [TBL] [Abstract][Full Text] [Related]
15. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl]. Germeshausen M; Schulze H; Gaudig A; Krukemeier S; Strauss G; Welte K; Ballmaier M Klin Padiatr; 2001; 213(4):155-61. PubMed ID: 11528548 [TBL] [Abstract][Full Text] [Related]
16. Biology and chemistry of thrombopoietic agents. Kuter DJ Semin Hematol; 2010 Jul; 47(3):243-8. PubMed ID: 20620435 [TBL] [Abstract][Full Text] [Related]
17. Clinical findings with the first generation of thrombopoietic agents. Vadhan-Raj S Semin Hematol; 2010 Jul; 47(3):249-57. PubMed ID: 20620436 [TBL] [Abstract][Full Text] [Related]
18. New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents. Metjian A; Abrams CS Biologics; 2009; 3():499-513. PubMed ID: 20054440 [TBL] [Abstract][Full Text] [Related]
19. Megakaryopoiesis and thrombopoiesis: an update on cytokines and lineage surface markers. Yu M; Cantor AB Methods Mol Biol; 2012; 788():291-303. PubMed ID: 22130715 [TBL] [Abstract][Full Text] [Related]
20. [Expression of thrombopoietin related genes in patients with idiopathic thrombocytopenic purpura]. Zhang X; Yang Y; Shi H Zhonghua Xue Ye Xue Za Zhi; 1998 Nov; 19(11):587-9. PubMed ID: 11263344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]